货号:A654863 同义名: SB-743921;SB-743921 (hydrochloride)
SB-743921 HCl是一种强效的 KIF11 抑制剂,Ki 值为 0.1 nM,具有极高的抑制效能,处于临床 1/2 期。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Kinesin ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SB-743921 HCl |
++++
KSP (P388 cells), IC50: 14.4 nM KSP, Ki: 0.07 nM |
99%+ | |||||||||||||||||
GSK-923295 |
++
CENP-E, Ki: 3.2 nM |
99%+ | |||||||||||||||||
Ispinesib |
+++
KSP (HsEg5), Ki app: 1.7 nM |
99%+ | |||||||||||||||||
AZ3146 |
+
Mps1, IC50: ~35 nM |
98+% | |||||||||||||||||
MPI-0479605 |
++
Mps1, IC50: 1.8 nM |
99%+ | |||||||||||||||||
BAY1217389 |
+++
Mps1, IC50: 0.63 nM |
98% | |||||||||||||||||
ARQ 621 | ✔ | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | SB-743921 is a second generation, highly potent and active KSP inhibitor with Ki of 0.1 nM, showing no affinity to MKLP1, Kin2, Kif1A, Kif15, KHC, Kif4 and CENP-E. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00136513 | Solid Tumor Cancer | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792 收起 << |
NCT00343564 | Non-Hodgkin's Lymphoma ... 展开 >> Hodgkin's Disease 收起 << | Phase 1 Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Cornell University Medical Center New York, New York, United States, 10021 Memorial Sloan-Kettering Caner Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Sarah Cannon Cancer Research Institute Nashville, Tennessee, United States, 37203 Russian Federation Russian Medical Academy of Postgraduate Education Moscow, Russian Federation, 115478 St. Petersburg State PAVLOV Medical University Saint Petersburg, Russian Federation, 197002 收起 << |
NCT00343564 | - | Completed | - | - |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.81mL 0.36mL 0.18mL |
9.03mL 1.81mL 0.90mL |
18.07mL 3.61mL 1.81mL |
CAS号 | 940929-33-9 |
分子式 | C31H34Cl2N2O3 |
分子量 | 553.519 |
别名 | SB-743921;SB-743921 (hydrochloride);SB-743921 hydrochloride |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,Store in freezer, under -20°C |
溶解方案 |
DMSO: 105 mg/mL(189.7 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 10 mg/mL(18.07 mM),配合低频超声,并水浴加热至45℃助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |